US FDA clears Sun Pharma plant; stock gains nearly 2%
US FDA completes inspection at Dadra plant and no data integrity issues. Dadra has been Sun Pharma’s only formulation plant which had no USFDA concerns.
Other Stocks Videos
Biocon to sell stake in biosimilar arm and Syngene: Sources
Stocks in news: Lupin, GMR Airports and more
Stocks in news: United Breweries, Tata Motors, Mazagon Dock and more
Manipal's Ranjan Pai acquires Rs 1,400 crore Davidson Kempner debt on BYJU's
Samvat 2080: 80 stock recommendations from top brokerage houses for your portfolio this new year
